Patents by Inventor Atrish Bagchi

Atrish Bagchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240368304
    Abstract: Disclosed herein are clones of murine F77 monoclonal antibodies, humanized F77 antibodies, single chain variable fragments (scFvs) and single chain antigen binding fragments (scFabs) of the antibodies, and chimeric antigen receptors. The humanized F77 antibodies and their fragments retain the binding specificity of the murine F77 monoclonal antibody to PC-3 cells. The humanized F77 antibodies and their fragments can be used for diagnostic and/or therapeutic tools in diagnosis or treatment of localized (stages I and II), locally advanced (stage III), or advanced (stage IV) prostate cancer.
    Type: Application
    Filed: May 3, 2024
    Publication date: November 7, 2024
    Inventors: Mark I. Greene, Hongtao Zhang, Zhiqiang Zhu, Zheng Cai, Payal Grover, Michael Milone, Selene Nunez-Cruz, Atrish Bagchi